- Grants since 2016
- 1 662
- Awarded, last 5 years (where amounts are published)
- £350.5M
- Funded works, last 5 years
- 11.8k
- Funded works, all time
- 52.4k
Grants
2024–2028 · fellowship · Intermediate Clinical Research Fellowships
Characterising the energetic phenotype of titin dilated cardiomyopathy – an essential step towards precision therapy
B Halliday · Imperial College London
2024–2027 · research · Project Grants
Ability of FGFR1/KLB to prevent cardiac microvascular impairment and pathological remodelling in response to metabolic stress
W Liu · University of Manchester
2024–2027 · research · 25/29910 be confirmed 3D spheroid model to study mechanisms and therapeutics
Can nitazene synthetic opioids exert cardiotoxicity linked to hERG potassium channel block?
M Chowdhury · University of Bristol
2024–2027 · fellowship · Clinical Research Training Fellowships
Prospective evaluation of a new clinical classification of myocardial infarction
F Thurston · University of Edinburgh
2024–2032 · research · Clinical Study Grants
The AntiPlatelet Therapy in Spontaneous Coronary Artery Dissection Trial (APT-SCAD Trial)
D Adlam · University of Leicester
2024–2027 · research · Project Grants
Manipulation of the endogenous monocyte/macrophage niche using mesenchymal stem cell-derived extracellular vesicles to revascularise the ischaemic leg
A Patel · King's College London
2024–2027 · research · 25/29910 be confirmed 3D spheroid model to study mechanisms and therapeutics
Understanding the role of lipid metabolism in heart failure
E Carter · University of Aberdeen
2024–2027 · research · Special Project Grants
Rebalancing the fat content of the heart and muscles in type 2 diabetes
D Dawson · University of Aberdeen
2024–2027 · research · Project Grants
Intravascular fibrin films: elucidating mechanisms of formation and roles in thrombosis development
F Macrae · University of Leeds
2024–2027 · research · Project Grants
Is aberrant arch artery development in Pax9-deficient mice a form of ribosomopathy?
S Bamforth · Newcastle University
2024–2027 · fellowship · Clinical Research Training Fellowships
Advanced pulmonary flow haemodynamic biomarkers in pulmonary hypertension
C Graftonclarke · University of East Anglia
2024–2029 · fellowship · Intermediate Basic Science Research Fellowships
New approach for functional nano-imaging of neuro-cardiac junctions
J L Sanchezalonso · Imperial College London
2024–2026 · research · Project Grants
Investigating co-factors that work alongside KLF2 and KLF4 to activate transcription
S De Val · University of Oxford
2024–2028 · training · 4-year PhD Studentships
KCL 4th intake, 2024 4-Year PhD Studentship (5th) Scheme: Miss Zahraa Bhatti; Miss Marta Bernardi; Miss Yirou Tang
A Ivetic · King's College London
2024–2029 · research · Consultant Research Award
Transforming the care of people with syncope using machine learning
M Dani · Imperial College London
2024–2027 · research · 25/29911 confirmed of a minimally-invasive ultrasound guided rat myocardial
High resolution innovative 3D anatomical reconstruction, with aid of AI, virtual and mixed reality, and computational modelling, of healthy young, heart failure and/or aged hearts: the story of mice and humans
A Arshad · University of Manchester
2024–2027 · research · Special Project Grants
Repurposing treatments for the rare disease propionic acidaemia to reverse disease-driving epigenetic changes in type-2 diabetic hearts arising from disturbed propionyl-CoA metabolism
P Swietach · University of Oxford
2024–2029 · fellowship · Intermediate Basic Science Research Fellowships
Modelling familial bicuspid aortic valve genetic variants with zebrafish
C Derrick · Newcastle University
2024–2027 · research · International Awards
Normalising Ventricular Conduction in Heart Failure by Gene Therapies (CONDUCTION-GTx). (Joint funding with the German Centre for Cardiovascular Research, the Dutch Heart Foundation and the Lefoulon-Delalande Foundation)
A D’Souza · Imperial College London
2024–2027 · research · Project Grants
Brown adipose tissue metabokines as therapeutics for cardiac dysfunction in heart failure
L Roberts · University of Leeds
2024–2027 · research · Project Grants
Investigation on the protective mechanism and therapeutic potential of the histone deacetylase-derived 7-amino acid peptide against cardiac fibrosis
L Zeng · King's College London
2024–2026 · research · Project Grants
Identifying a new role for the carotid body in mediating cardiovascular responses to heat stress
A Holmes · University of Birmingham
2024–2029 · fellowship · Intermediate Clinical Research Fellowships
Personalised care for young people with dilated cardiomyopathy
G Norrish · University College London
2024–2027 · research · Project Grants
Targeting the QKI-7 restores vasculopathy in blood vessels in diabetes
A Margariti · Queen's University Belfast
2024–2025 · research · Project Grants
Joint NC3Rs/BHF Partnership and Impact Award: Modification and validation of a human endothelialised in vitro thrombosis model to promote end-user uptake
S Jones · Manchester Metropolitan University
2024–2028 · fellowship · Immediate Postdoctoral Basic Science Research Fellowships
Inflammation and immune checkpoint inhibitors: double-edged swords at the intersection of cancer therapies, cardio-oncology and cardiovascular disease
K C Park · University of Oxford
2024–2027 · research · Project Grants
Myocardial fibrosis and left ventricular remodelling in cardiovascular disease
A Tavares · University of Edinburgh
2024–2027 · research · Project Grants
Development of endothelial cell-targeted therapeutic exosomes by genome editing of their parental stem cells
C Emanueli · Imperial College London
2024–2027 · research · Strategic Initiatives
Academy of Medical Sciences Mentoring Programme
2024–2029 · fellowship · Intermediate Clinical Research Fellowships
Why is lamin cardiomyopathy a perfect storm for arrhythmias? A study of pro-arrhythmic Ca2+ handling and its treatment with phosphodiesterase-5 inhibitors
D Hutchings · University of Manchester
2024–2027 · research · 25/29910 be confirmed 3D spheroid model to study mechanisms and therapeutics
Development of PROTAC-based technology to inhibit inflammation by targeting the neutrophil extracellular trap – NLRP3 inflammasome axis
T Woolhouselorber · University of Birmingham
2024–2029 · fellowship · Intermediate Basic Science Research Fellowships
Studying the full-length structure of the GPVI receptor complex in the membrane: identifying novel sites of selective inhibition and antiplatelet activity
A Slater · University of Birmingham
2024–2027 · research · Project Grants
Targeting VWF-platelet priming and immunothrombosis for the prevention of venous thrombosis
I Sallescrawley · City St George's, University of London
2024–2027 · fellowship · Research Training Fellowships (for Nurses and Allied Health Professionals)
Magnetic resonance imaging of primary lymphoedema: a tool for diagnosis and evaluating treatment
M Mills · City St George's, University of London
2024–2027 · research · Project Grants
Molecular basis for oxidised low density lipoprotein interaction with the scavenger receptor LOX-1
M Harrison · University of Leeds
2024–2028 · research · Special Project Grants
Spontaneous coronary artery dissection: investigating the role of female sex hormones in disease pathophysiology
D Adlam · University of Leicester
2024–2027 · fellowship · Clinical Research Training Fellowships
Development of an artificial intelligence model to quantify plaque vulnerability and predict plaque events using routine computed tomography angiography
K Chan · University of Oxford
2024–2027 · research · Project Grants
Investigation of SLIT3 sequence variants as genetic contributors to congenital heart disease
K Hentges · University of Manchester
2024–2027 · research · 25/29910 be confirmed 3D spheroid model to study mechanisms and therapeutics
Attenuation of damage to endothelium in transplanted heart by targeting the IL-6/S1P signalling axis
M Bower · Newcastle University
2024–2027 · research · 25/29910 be confirmed 3D spheroid model to study mechanisms and therapeutics
The dynamic duo: how p16 and p21 drive senescence in cardiovascular disease
L Mathison · Newcastle University